Total debt issuance costs classified as a reduction to long-term debt and lease obligations (current and non-current).

No definition available.

Name:	abbv_DebtIssuanceCostsClassifiedAsReductionToLongTermDebtAndLeaseObligationsCurrentAndNonCurrent
Namespace Prefix:	abbv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Net deferred financing costs were reclassified to a reduction in the carrying amount of its long-term debt.

No definition available.

Name:	abbv_NetDeferredFinancingCostsReclassifiedToReduceCarryingAmountOfLongTermDebt
Namespace Prefix:	abbv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Represents the number of principal U.S. customers of the entity.

No definition available.

Name:	abbv_NumberOfPrincipalUSCustomers
Namespace Prefix:	abbv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

No definition available.

Name:	abbv_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems
Namespace Prefix:	abbv_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Represents the percentage of outstanding common stock distributed to shareholders.

No definition available.

Name:	abbv_PercentageOfOutstandingCommonStockDistributed
Namespace Prefix:	abbv_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Represents the amount of separation-related expenses, including legal, information technology and regulatory fees, incurred by the entity.

No definition available.

Name:	abbv_SeparationRelatedExpenses
Namespace Prefix:	abbv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

No definition available.

Name:	us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Name:	us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_NewAccountingPronouncementEarlyAdoptionEffectMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	dei_LegalEntityAxis=abbv_ReportingEntitySponsorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Background and Basis of Presentation (Details) $ in Millions		3 Months Ended		9 Months Ended
	Jan. 02, 2013	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($) customer	Sep. 30, 2014 USD ($)	Dec. 31, 2014 USD ($)
Background and Basis of Presentation
Number of wholesalers \| customer				3
Separation-related expenses		$ 45	$ 109	$ 244	$ 299
Recent Accounting Prounouncements
Recent Accounting Pronouncements
Debt issuance costs classified as a reduction to long-term debt and lease obligations (current and non-current)		$ 118		$ 118
Prepaid expenses and other current assets \| Recent Accounting Prounouncements
Recent Accounting Pronouncements
Net deferred financing costs reclassified to a reduction in the carrying amount of its long-term debt						$ 7
Other long-term assets \| Recent Accounting Prounouncements
Recent Accounting Pronouncements
Net deferred financing costs reclassified to a reduction in the carrying amount of its long-term debt						$ 27
AbbVie sponsored plans
Background and Basis of Presentation
Percentage of outstanding common stock distributed to Abbott Laboratories' shareholders	100.00%